New test identifies high-risk childhood brain tumours, improving treatment decisions
Canadian researchers have developed an effective new technique for identifying aggressive medulloblastoma—the most common type of...
Mar 13
Research discovery halts childhood brain tumor before it forms
Scientists at The Hospital for Sick Children (SickKids) have discovered a way to stop tumor growth before it starts for a subtype of...
Feb 7
Targeting potassium channel shows promise for treating brain tumors in children
Scientists at The Hospital for Sick Children (SickKids) have identified a key gene that could lead to next-generation treatments for...
Jan 28
New study finds kinder, more targeted approach to treating aggressive childhood brain cancer
The discovery of an aggressive genetic group will lead to better patient management of this form of tumour, which urgently requires new...
Oct 8, 2024
Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma
A drug that was developed to treat pancreatic cancer has now been shown to increase symptom-free survival in preclinical medulloblastoma...
Aug 13, 2024
Unexpected role of OTX2 drives aggressive medulloblastoma
Researchers revealed an unexpected way in which the protein OTX2 drives the progression of medulloblastoma -- the most common aggressive...
Jul 26, 2024
Stem-like cells found to drive growth of aggressive pediatric brain tumors
A team of researchers at Baylor College of Medicine, Texas Children's Hospital, the Hospital for Sick Children in Toronto and...
Jul 16, 2024
Advances in medulloblastoma treatment for children
Dr. Schwartz explains how medulloblastoma is treated, the latest treatment advances and what families should look for in a care team....
Jun 21, 2024
The 10-minute test for childhood tumours
Children with cancer could have an accurate brain tumour diagnosis in 10 minutes, thanks to new research. Read more:...
Jun 13, 2024
Targeting specific protein regions offers a new treatment approach in medulloblastoma
Scientists at St. Jude Children’s Research Hospital discovered a new compound that selectively targets parts of a cancer-related protein,...
May 17, 2024